STOCK TITAN

Niki BioSolutions (NIKI) Net Income by Year

NIKI NASDAQ

Niki BioSolutions, Inc. reported a net loss of $1.4M in fiscal year 2025. The change from the prior fiscal year is not meaningful, because that figure was zero or negative. The table below carries 8 fiscal years, from 2018 to 2025.

FY2025 annual
Net Income -$1.4M
YoY n/m

Ticker history: APM became NIKI (Niki BioSolutions, Inc.) on . Earlier news and filings retain their original names and dates. View APM history.

Source SEC Filings Latest period FY2025, ended Dec 31, 2025 Reported Currency USD

Annual figures, oldest first. Point at a bar to read its period.

NIKI Net Income by Fiscal Year

Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.

MetricFY25FilingFY24FilingFY23FilingFY22FilingFY21FilingFY20FilingFY19FilingFY18Filing
Net Income-$1.4Mn/m-$4.3Mn/m-$2.8Mn/m-$9.8Mn/m-$25.0M-609.1%$4.9Mn/m-$20.1Mn/m-$14.8M

What net income means

Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line.

More Niki BioSolutions, Inc. financials

Frequently Asked Questions

Niki BioSolutions, Inc. reported a net loss of $1.4M in fiscal year 2025.

Niki BioSolutions, Inc. (NIKI) reported a $4.3M net loss in fiscal year 2024 and a $1.4M net loss in fiscal year 2025. A growth rate is not meaningful here, because the earlier figure was zero or negative.

Across the 8 fiscal years this page covers, Niki BioSolutions, Inc. (NIKI) net income went from -$14.8M in fiscal year 2018 to -$1.4M in fiscal year 2025.

Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line. This page lists what Niki BioSolutions, Inc. (NIKI) reported on that line in every period on record.